Sentien Has Pre-IND meeting with FDA’s Center for Biologics Evaluation and Research
In preparation for a first-in-man study, Sentien participated in pre-IND meeting with the FDA’s Center for Biologics Evaluation and Research.
In preparation for a first-in-man study, Sentien participated in pre-IND meeting with the FDA’s Center for Biologics Evaluation and Research.